Showing results (171-180 of 190) with videos related to
Sort By:
Pageof 19
Oncotarget|December 22, 2017
The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewing's sarcoma with a FUS-ERG fusion and CDKN2A deletion: Direction for third-line patient therapyKentaro Miyake, Takashi Murakami, Tasuku Kiyuna, et al.Tissue & Cell|October 13, 2018
Tumor-targeting Salmonella typhimurium A1-R overcomes partial carboplatinum-resistance of a cancer of unknown primary (CUP)Kentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, et al.Oncotarget|April 14, 2017
Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse modelTakashi Murakami, Shukuan Li, Qinghong Han, et al.Biochemical and Biophysical Research Communications|November 6, 2018
Metabolic targeting with recombinant methioninase combined with palbociclib regresses a doxorubicin-resistant dedifferentiated liposarcomaKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.Journal of Cellular Biochemistry|November 17, 2017
Growth of doxorubicin-resistant undifferentiated spindle-cell sarcoma PDOX is arrested by metabolic targeting with recombinant methioninaseKentaro Igarashi, Shukuan Li, Qinghong Han, et al.Cancer Letters|January 7, 2018
Recombinant methioninase in combination with doxorubicin (DOX) overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcomaKentaro Igarashi, Kei Kawaguchi, Shukuan Li, et al.Bone Research|December 11, 2020
Evading the host response: Staphylococcus "hiding" in cortical bone canalicular system causes increased bacterial burdenStephen D Zoller, Vishal Hegde, Zachary D C Burke, et al.Surgery|October 10, 2025
Dedicated review of sarcoma pathology is necessary for corroborative diagnosis in nearly one half of referred patientsMark A Eckardt, Nicholas M Siena, Amy R Copeland, et al.Chemotherapy|January 24, 2019
Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing's Sarcoma in a Patient-Derived Orthotopic Xenograft ModelKentaro Miyake, Tasuku Kiyuna, Shukuan Li, et al.Oncotarget|May 4, 2018
Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse modelKentaro Igarashi, Kei Kawaguchi, Shukuan Li, et al.Pageof 19